Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial: B. Scott et al

Bart L. Scott, Marcelo C. Pasquini, Mingwei Fei, Raphael Fraser, Juan Wu, Steve M. Devine, David L. Porter, Richard T. Maziarz, Erica Warlick, Hugo F. Fernandez, Robert J. Soiffer, Edwin Alyea, Mehdi Hamadani, Asad Bashey, Sergio Giralt, Nancy L. Geller, Eric Leifer, Christopher S. Hourigan, Gege Gui, Adam MendizabalMary M. Horowitz, H. Joachim Deeg, Mitchell E. Horwitz

Research output: Contribution to journal › Article › peer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial: B. Scott et al'. Together they form a unique fingerprint.

Medicine & Life Sciences